Notice of Intent to Sole Source – Illumina
Closed Special Notice Posted
- Solicitation number
- 26-000209
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Clinical Center has issued a Notice of Intent to Sole Source a one-year maintenance agreement for two NextSeq 1000 Sequencers to Illumina, Inc. This Special Notice was posted on December 19, 2025, and represents the NIH Department of Laboratory Medicine's intent to award a firm fixed price purchase order on a sole source basis. The acquisition falls under Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures, which permits single-source procurement when circumstances warrant only one source as reasonably available. The contracting officer has determined that Illumina is the only viable source for the required maintenance services, and this award is exempt from FAR Part 6 competition requirements. The notice provides interested parties an opportunity to identify their interest and capabilities, though the government retains sole discretion to proceed with the Illumina award.
The primary objective of this acquisition is to secure maintenance support for two specific NextSeq 1000 Silver Support Plan units (catalog number 20040648) located at the NIH's Bethesda, Maryland facility. The contracting officer asserts that because Illumina manufactures and exclusively services the NextSeq 1000 sequencer, no alternative sources exist for this specialized maintenance agreement. The deadline for interested parties to respond to this notice is December 23, 2025. There are no specific eligibility criteria imposed, as the notice invites any interested parties to express their capabilities, though the government's final determination to compete or proceed with the sole source award remains at its discretion. This procurement is classified under Product Service Code 6515 (Medical Instruments, Equipment, and Supplies) and NAICS Code 339112 (Surgical and Medical Instrument Manufacturing).
Notice text
The purpose of this acquisition for a 1 year maintenance agreement for two Nextseq 1000
Sequencers at the National Institutes of Health (NIH) Department of Laboratory Medicine (DLM).
• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies
• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 26-000209
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Illumina, Inc., located at 5200 Illumina Way, San Diego, CA 92122, on a firm fixed price sole source award basis to provide a 1 year maintenance agreement for two Nextseq 1000 Sequencers at the National Institutes of Health (NIH) Department of Laboratory Medicine (DLM).
Below is a description of the item(s):
Description: NextSeq 1000 Silver Support Plan, VL00633 and VL00637
Units: Each
Qty: 2
Catalog #: 20040648
The Nextseq 1000 sequencer is manufactured and services only by Illumina Inc.
There is no other source for this service.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by December 23, 2025 at 12pm EST.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside | |
| Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 | Naval Supply Systems Command | No set-aside | |
| Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 | Naval Supply Systems Command | No set-aside | |
| Notice of Intent to Sole Source – Boston Scientific | NIH Clinical Center | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity